Allan R Shatzman

Title: Allan R. Shatzman: Innovator in Biopharmaceuticals

Introduction

Allan R. Shatzman is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of methods for producing physiologically active polypeptides. With a total of 5 patents to his name, Shatzman has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents is a method for preparing a physiologically active IL-18 polypeptide. This invention provides a novel approach to producing human Interleukin-18 (IL-18), which is crucial for various therapeutic applications. Another significant patent involves a method for producing a physiologically active polypeptide by contacting a precursor polypeptide with an activating enzyme or co-expressing it with an activating protease. These innovations highlight his commitment to advancing medical science.

Career Highlights

Allan R. Shatzman has worked with SmithKline Beecham Corporation, where he has been able to apply his expertise in biopharmaceuticals. His work has contributed to the development of important medical treatments and has had a lasting impact on the industry.

Collaborations

Throughout his career, Shatzman has collaborated with notable colleagues, including Lois L. Hoyer and George P. Livi. These partnerships have fostered innovation and have been instrumental in the success of his projects.

Conclusion

Allan R. Shatzman is a distinguished inventor whose work in biopharmaceuticals has led to significant advancements in the field. His contributions, particularly in the area of IL-18 polypeptide production, demonstrate his dedication to improving healthcare through innovation.